The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy

5-Fluorouracil (5-FU)-based chemotherapy is the first-line treatment for colorectal cancer (CRC) but is hampered by chemoresistance. Despite its impact on patient survival, the mechanism underlying chemoresistance against 5-FU remains poorly understood. Here, we identified serine hydroxymethyltransf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian, Na, Risi, Xiao, Chao, Wang, Xiao, Wang, Yupeng, Yan, Dongwang, Song, Guohe, Liu, Xueni, Chen, Jiayi, Lu, Huijun, Chen, Chunyan, Tang, Huamei, Zhuang, Guohong, Fan, Guangjian, Peng, Zhihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195740/
https://www.ncbi.nlm.nih.gov/pubmed/33990700
http://dx.doi.org/10.1038/s41388-021-01815-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195740/
https://www.ncbi.nlm.nih.gov/pubmed/33990700
http://dx.doi.org/10.1038/s41388-021-01815-4

Ejemplares similares